NASDAQ
77.00USD
-2.21 (-2.79%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
3B
P/E
—
EPS
—
Beta
2.07
52W range
40-99.5
Day range
75.12–79.31
Open
78.71
Prev close
79.21
Volume
355.4K
Avg volume
569K
Dividend
0.00
IPO
2020-08-12
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302840409.html · 8/1/2026-1.00
https://www.newsfilecorp.com/release/306046/ROSEN-A-LONGSTANDING-FIRM-Encourages-Blaize-Holdings-Inc.-Investors-to-Inquire-About-Securities-Class-Action-Investigation-BZAI · 7/22/2026-0.80
https://www.newsfilecorp.com/release/306049/ROSEN-A-LEADING-LAW-FIRM-Encourages-NanoX-Imaging-Ltd.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-NNOX · 7/22/2026-0.80
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302825445.html · 7/14/2026-1.00
https://www.proactiveinvestors.co.uk/companies/news/1095397 · 7/14/2026+1.00
https://www.newsfilecorp.com/release/304843/ZOETIS-DEADLINE-ROSEN-SKILLED-INVESTOR-COUNSEL-Encourages-Zoetis-Inc.-Investors-with-Losses-in-Excess-of-100K-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-ZTS · 7/12/2026-0.50
https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302822558.html · 7/10/2026-1.00
https://www.globenewswire.com/news-release/2026/07/02/3321064/673/en/Disc-Medicine-Investor-News-If-You-Have-Suffered-Losses-in-Disc-Medicine-Inc-NASDAQ-IRON-You-Are-Encouraged-to-Contact-The-Rosen-Law-Firm-About-Your-Rights.html · 7/2/2026-1.00
https://www.newsfilecorp.com/release/303541/ROSEN-GLOBAL-INVESTOR-COUNSEL-Encourages-GRAIL-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-GRAL · 6/30/2026-0.50
https://www.newsfilecorp.com/release/303123/ROSEN-RECOGNIZED-INVESTOR-COUNSEL-Encourages-UP-Fintech-Holding-Limited-Investors-to-Inquire-About-Securities-Class-Action-Investigation-TIGR · 6/27/2026-0.80
https://www.newsfilecorp.com/release/302431/ROSEN-A-RANKED-AND-LEADING-LAW-FIRM-Encourages-Wise-Group-plc-Investors-to-Inquire-About-Securities-Class-Action-Investigation-WSE · 6/22/2026-0.50
https://www.newsfilecorp.com/release/302231/ROSEN-THE-FIRST-FILING-FIRM-Encourages-ADMA-Biologics-Inc.-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-First-Filed-by-the-Firm-ADMA · 6/20/2026-0.80
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
